Member Info for xviolet

Yes. It all sounds good!

Polygon been shopping for SYN. Good sign, I guess. RNS at SYN.

Is this as good as a EUA? more grown-ups with brains buying shares. not people like me who don't know anything.
Kind of a signal isn't it? Green light, boom and all that.

trrime

that's a great post. it would make a good t-shirt.

Bigeasy

Hope you and your partner recover and the experience becomes less painful. From reading at least one of the replies to your earlier posting I can't help feeling that you are not the one who is sick. Takecare.

ihowells...

Ha! No. Got that all wrong-ish. Bought some at 9.4. And some at 8.4
I'm so glad I've learned to buy in small tranches!
Might hold for a while. SAR seems to have great support so that will hopefully keep things bubbling away.

And while I'm trying to stay skeptical - the non-skeptical reading of SAR is explosive/unicornMAX multi-bag.

SP keeps going up. I don't understand the science. But very strong sentiment on BB - possibly not always rational - I am content to hold SAR but also trying to trade on the sentiment.

riotud77...

As I am 'impatient and greedy' I have been trying to make time to study the 78 covid therapeutics listed below...and there may well be more in development and testing. ..but as I study this list it that helps me to think about SAR options and prices.

https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-therapeutics-tracker

sezz

thanks for that.

BRH? bought it twice, lost money both times!
Would only buy again around pre-COVID prices - 10-14p - I can't read the market for LFTs but Alzheimer's test bears trace of hope. Not that excited about BRH - don't have spare cash - but watching the lows at DMTR, BZT, LYS, WRES, GGP and OEX. Might jump at one of those.

Does RMM have some room to move/uptick? Wondered if anyone thinks RMM might re-rate?

Finally got around to reading what Thoth was posting the other day. Here is the original document Thoth's article was referencing. It may be a game changer in reference to covid therapeutics and therefore SAR's value. I don't have the pharma background to get the big picture - but its definitely worth a read. Because potentially it knocks out a whole class of C19 treatments....like a massive chunk of the competition just bit the dust. Or might do.

"Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) usually result from random mutations in humans or other hosts, but accelerated evolution can also occur under selective pressure from therapeutic interventions using neutralizing antibodies"

https://wwwnc.cdc.gov/eid/article/27/10/21-1538_article

"Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) usually result from random mutations in humans or other hosts, but accelerated evolution can also occur under selective pressure from therapeutic interventions using neutralizing antibodies"

https://wwwnc.cdc.gov/eid/article/27/10/21-1538_article

bite the dust....?

https://wwwnc.cdc.gov/eid/article/27/10/21-1538_article

crikey! blimey!
sorry no offence meant.

caterham? filter it.
reads like the letters page from viz.
if not a paid deramper, certainly reads like one.
perhaps a sign the sp is about climb.

secret messages? laughable.
more seriously the next few days/couple of weeks must be last chance to top up on first drill. or today and tomorrow might be the last chances sub 30p.

Thanks John, Thanks 1509

please keep the COPL guidance coming!

Nolupus

Thanks for reply. LYS must be close to bottom - so on my watchlist!